Researcher
Jan De Bleecker
- Disciplines:Neurological and neuromuscular diseases, Histology, Neuroanatomy, Musculo-skeletal systems, Neurophysiology, Inflammation, Neurosciences not elsewhere classified
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Feb 1999 → 30 Sep 2018
Publications
1 - 10 of 86
- Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+) : interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis(2024)
Authors: James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Peric, Jan De Bleecker, Hiroyuki Murai, Andreas Meisel, Said R. Beydoun, Mamatha Pasnoor, et al.
- Anoctamin-5 related muscle disease : clinical and genetic findings in a large European cohort(2023)
Authors: Alexander de Bruyn, Federica Montagnese, Sonja Holm-Yildiz, Nanna Scharff Poulsen, Tanya Stojkovic, Anthony Behin, Johanna Palmio, Manu Jokela, Jan De Bleecker, Marianne de Visser, et al.
Pages: 3800 - 3815 - Exome sequencing and multigene panel testing in 1,411 patients with adult-onset neurologic disorders(2023)
Authors: Nika Schuermans, Hannah Verdin, Jody Ghijsels, Madeleine Hellemans, Elke Debackere, Elke Bogaert, Sofie Symoens, Leslie Naesens, Elien Lecomte, David Crosiers, et al.
- Wat zijn de ervaringen van personen met amyotrofische laterale sclerose (ALS) en hun mantelzorgers met vroegtijdige zorgplanning?(2023)
Authors: Isabel Vandenbogaerde, Lieve Van den Block, Luc Deliens, Emma Carduff, Agnes van der Heide, Jan De Bleecker, Aline De Vleminck, Jean-Emile Vanderheyden
Pages: 25 - 30 - HATTR-polyneuropathie : diagnose en behandeling(2022)
Authors: Jan De Bleecker, Elke De Vos
Pages: 14 - 15 - Two-years prospective natural history study in 24 adult LGMDR12 patients : clinical and radiological outcome measures(2022)Volume: 9
Authors: B De Wel, L Huysmans, R Peeters, V Goosens, S Ghysels, K Byloos, G Putzeys, A D'Hondt, Jan De Bleecker, P Dupont, et al.
Pages: S170 - S171 - Neuromusculaire aandoeningen(2022)
Authors: NBM Voet, Jan De Bleecker, JHB Geertzen, JS Rietman, GG Vanderstraeten, RJ Berduszek, K Oostra, B Fard
Pages: 133 - 146 - Belgian retrospective survey of hereditary transthyretin-mediated (hATTR) amyloidosis patients treated with patisiran in real-world practice(2022)Volume: 9
Authors: S Tilleux, Jan De Bleecker, K Claeys, S Destanche, V Van Parys, Jonathan Baets, G Remiche
Pages: S273 - S274 - Unraveling the molecular basis of the dystrophic process in limb-girdle muscular dystrophy LGMD-R12 by differential gene expression profiles in diseased and healthy muscles(2022)
Authors: Christophe E. Depuydt, Veerle Goosens, Rekin’s Janky, Ann D’Hondt, Jan De Bleecker, Nathalie Noppe, Stefaan Derveaux, Dietmar R. Thal, Kristl G. Claeys
- Hematological effects of intravenous immunoglobulin therapy in patients with neuromuscular diseases : a retrospective analysis(2022)Volume: 9
Authors: Jan De Bleecker
Pages: S226 - S227